XENO TRANSPLANTS CORPORATIONXX

XENO TRANSPLANTS CORPORATION

0.000100USDD
0.0000000.00%
Last update at Dec 16, 2024, 14:37 GMT
USD
No tradesPre-market
See on Supercharts

XENO fundamentals

Key facts

Market capitalization‪4.04 K‬USD
Founded2004
CEO
Website
About

Xeno Transplants Corp. operates as a bio-technology research and development company. It intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources. The company was founded on October 5, 2004 and is headquartered in Vancouver, Canada.

Ownership
‪‪40.36 M‬‬
Free Float shares
‪‪21.74 M‬‬ (53.86%)
Closely held shares
‪‪18.63 M‬‬ (46.14%)
Free Float shares
‪‪21.74 M‬‬ (53.86%)
Closely held shares
‪‪18.63 M‬‬ (46.14%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪4.04 K‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
2020
2021
2022
2023
2024

Growth and Profitability

Company’s recent performance and margins

Performance
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Dividends

Dividend yield, history and sustainability

XENO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
2020
2021
2022
2023
2024
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.